An action plan for pan-European defence against new SARS-CoV-2 variants
Lancet
.
2021 Feb 6;397(10273):469-470.
doi: 10.1016/S0140-6736(21)00150-1.
Epub 2021 Jan 21.
Authors
Viola Priesemann
1
,
Rudi Balling
2
,
Melanie M Brinkmann
3
,
Sandra Ciesek
4
,
Thomas Czypionka
5
,
Isabella Eckerle
6
,
Giulia Giordano
7
,
Claudia Hanson
8
,
Zdenek Hel
9
,
Pirta Hotulainen
10
,
Peter Klimek
11
,
Armin Nassehi
12
,
Andreas Peichl
13
,
Matjaz Perc
14
,
Elena Petelos
15
,
Barbara Prainsack
16
,
Ewa Szczurek
17
Affiliations
1
Max-Planck-Institute for Dynamics and Self-Organization, 37077 Göttingen, Germany. Electronic address:
[email protected]
.
2
University of Luxembourg, Luxembourg, Luxembourg.
3
Technische Universität Braunschweig, Helmholtz Zentrum für Infektionsforschung, Braunschweig, Germany.
4
University Hospital, Goethe-University Frankfurt, Frankfurt, Germany.
5
Institute for Advanced Studies, Vienna, Austria; London School of Economics and Political Science, London, UK.
6
University Hospital Geneva, Geneva, Switzerland.
7
University of Trento, Trento, Italy.
8
London School of Hygiene & Tropical Medicine, London, UK; Karolinska Institute, Stockholm, Sweden.
9
University of Alabama at Birmingham, Birmingham, AL, USA.
10
Minerva Foundation Institute for Medical Research, Helsinki, Finland.
11
Medical University of Vienna, Vienna, Austria; Complexity Science Hub Vienna, Vienna, Austria.
12
Ludwig-Maximilian-Universität München, Munich, Germany.
13
ifo Institute, Leibniz Institute for Economic Research, University of Munich, Munich, Germany.
14
University of Maribor, Maribor, Slovenia; Alma Mater Europaea, Maribor, Slovenia.
15
University of Crete, Crete, Greece.
16
Department of Political Science, University of Vienna, Vienna, Austria.
17
Faculty of Mathematics, Informatics and Mechanics, University of Warsaw, Warsaw, Poland.
PMID:
33485462
PMCID:
PMC7825950
DOI:
10.1016/S0140-6736(21)00150-1
No abstract available
Publication types
Letter
MeSH terms
COVID-19 / epidemiology
COVID-19 / prevention & control*
COVID-19 / virology*
Europe / epidemiology
Humans
SARS-CoV-2*